Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.

ABSTRACT: Significant progress has been made in the advancement of RNAi therapeutics by combining a synthetic triantennary N-acetylgalactosamine ligand targeting the asialoglycoprotein receptor with chemically modified small interfering RNA (siRNA) designs, including the recently described Enhanced Stabilization Chemistry. This strategy has demonstrated robust RNAi-mediated gene silencing in liver after subcutaneous administration across species, including human. Here we demonstrate that substantial efficacy improvements can be achieved through further refinement of siRNA chemistry, optimizing the positioning of 2'-deoxy-2'-fluoro and 2'-O-methyl ribosugar modifications across both strands of the double-stranded siRNA duplex to enhance stability without compromising intrinsic RNAi activity. To achie

SUBMITTER: Foster DJ 

PROVIDER: S-EPMC5910670 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature